Role of angiotensin II in diabetic nephropathy

Kidney International, Supplement

Volumn 58, Issue 77, 2000, Pages

  Leehey, D J ^a   Singh, A K ^a   Alavi, N ^a   Singh, R ^a  

^a Surgical Services Edward Hines Veterans Affairs Hospital   (United States)

Author keywords

Angiotensin; Diabetes; Glucose; Matrix

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; COLLAGENASE; CYTOKINE ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; GLUCOSE; NITRIC OXIDE; PLASMIN; PROTEINASE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA; ANGIOTENSIN II; ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIN; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

DIABETIC NEPHROPATHY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CELL CULTURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; DIABETIC NEPHROPATHIES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELINS; EXTRACELLULAR MATRIX; GLUCOSE; HUMANS; LYMPHOKINES; NITRIC OXIDE; RENIN-ANGIOTENSIN SYSTEM; STRESS, MECHANICAL; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033851637     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07715.x     Document Type: Review

References (64)

1. Differential expression of basement membrane collagen chains in diabetic nephropathy
2. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats
3. Renal glomerular collagen synthesis in streptozotocin diabetes: Reversal of increased basement membrane synthesis with insulin therapy
4. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium
5. Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells
6. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells
7. Early increased renal procollagen 1 (IV) mRNA levels in streptozotocin induced diabetes
8. Effect of glucose and heparin on mesangial 1 (IV) COLL and MMP-2/TIMP-2 mRNA expression
9. Renal proteinases and kidney hypertrophy in experimental diabetes
10. STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats
11. Decreased proteinase activity in the streptozotocin diabetic rat
12. Decreased degradative enzymes in mesangial cells cultured in high glucose media
13. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM
14. High glucose concentration causes a decrease in mesangium degradation: A factor in the pathogenesis of diabetic nephropathy
15. Modulation of neutral proteinase expression in human mesangial cells by hyperglycaemic culture
16. Long term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
17. Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism
18. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
19. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats
20. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats
21. The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
22. Role of angiotensin II in diabetic nephropathy
23. Altered synthesis of renin in patients with insulin-dependent diabetes: Plasma prorenin as a marker predicting the evolution of nephropathy
24. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat
25. Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat
26. Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus
27. Regulation of angiotensin II receptors and PKC isoforms by glucose in rat mesangial cells
28. Renin-angiotensin system in diabetic rats: Functional, immunohistochemical, and molecular biologic correlations
29. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy
30. Endogenous angiotensin concentrations in specific intrarenal fluid compartments in the rat
31. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
32. High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell culture
33. The role of proteinuria in the progression of chronic renal failure
34. In vitro production of angiotensin II by isolated glomeruli
35. Mechanical stretch/relaxation stimulates a cellular reninangiotensin system in cultured rat mesangial cells
36. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture
37. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation
38. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells
39. Angiotensin II stimulated extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular cells
40. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells
41. Angiotensin II stimulates fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors
42. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells
43. Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells
44. Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes
45. Angiotensin II-induced cellular hypertrophy: Potential role of impaired proteolytic activity in cultured LLC-PK1 cells
46. Cytokines in kidney disease: The role of transforming growth factor-beta
47. mRNA expression of growth factors in glomeruli from diabetic rats
48. Diabetic kidney disease is linked to elevated expression of transforming growth factor-beta
49. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β
50. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycemia
51. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta
52. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β
53. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
54. Human mesangial cell and peripheral blood mononuclear cells produce vascular permeability factor
55. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle
56. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells
57. Intreraction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by mesangial cells
58. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
59. Vascular endothelial growth factor and diabetic nephropathy
60. The renin-angiotensin system in diabetic nephropathy: The endothelial connection
61. Vasoactive substances as regulators of renal growth
62. Inhibition of rat mesangial cell mitogenesis by nitric-oxide generating vasodilators
63. Angiotensin II, nitric oxide, and end-organ damage in hypertension
64. Angiotensin II induces superoxide anion production by mesangial cells